Biotech · Private company · Atlanta, GA, US
Metaclipse Therapeutics Corporation
Track this companyFree. Adds Metaclipse Therapeutics Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- TMV VaccinePhase 1 · Squamous Cell Carcinoma of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- Toripalimab-tpziPhase 1 · Squamous Cell Carcinoma of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell CarcinomaPHASE1 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07898124 · fetched Nov 12, 2026
NIH awards1
- SBIR CONCEPT AWARD FOR DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERSFiscal year 2025 · $355KNIH RePORTER 75N91025C00038-0-9999-1 · fetched Nov 12, 2026